Shanghai Genomics Overview
- Year Founded
-
2001

- Status
-
Acquired/Merged
- Employees
-
93

- Latest Deal Type
-
M&A
Shanghai Genomics General Information
Description
Developer of therapeutics for the treatment of lung diseases. The company engages in the development of bio materials, drugs and therapeutic products which are used in the treatment of lung fibrosis, hepatocirrhosis, viral infections and fractured bones.
Contact Information
Website
www.shanghaigenomics.comCorporate Office
- Building 6, 230 Chuanhong Road
- Chuansha, Pudong New Area
- Shanghai, 201202
- China
Corporate Office
- Building 6, 230 Chuanhong Road
- Chuansha, Pudong New Area
- Shanghai, 201202
- China
Shanghai Genomics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 20-Jun-2005 | Completed | Generating Revenue | |||
1. Early Stage VC | 01-Aug-2001 | Completed | Startup |
Shanghai Genomics Patents
Shanghai Genomics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20140249347-A1 | Use of pyridone derivatives in the prevention or treatment of tissue or organ toxicity induced by cytotoxic agents and radiation | Inactive | 15-Jun-2006 | ||
EP-2036555-A1 | The use of derviate of pyridone for preventing and treating radioactive injury of lungs | Active | 15-Jun-2006 | ||
EP-2036555-B1 | The use of pyridone derivatives for preventing and treating radiation injury of lungs | Active | 15-Jun-2006 | ||
EP-2036555-A4 | The use of derviate of pyridone for preventing and treating radioactive injury of lungs | Active | 15-Jun-2006 | ||
US-20080037124-A1 | Optical member and manufacturing method thereof | Inactive | 31-Mar-2004 | G02B5/18 |
Shanghai Genomics Signals
Shanghai Genomics Former Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Shanghai Venture Capital | Venture Capital | Minority | ||
Zhangjiang Group | Limited Partner | Minority |
Shanghai Genomics FAQs
-
When was Shanghai Genomics founded?
Shanghai Genomics was founded in 2001.
-
Where is Shanghai Genomics headquartered?
Shanghai Genomics is headquartered in Shanghai, China.
-
What is the size of Shanghai Genomics?
Shanghai Genomics has 93 total employees.
-
What industry is Shanghai Genomics in?
Shanghai Genomics’s primary industry is Therapeutic Devices.
-
Is Shanghai Genomics a private or public company?
Shanghai Genomics is a Private company.
-
What is Shanghai Genomics’s current revenue?
The current revenue for Shanghai Genomics is
. -
How much funding has Shanghai Genomics raised over time?
Shanghai Genomics has raised $5.2M.
-
Who are Shanghai Genomics’s investors?
Shanghai Venture Capital and Zhangjiang Group have invested in Shanghai Genomics.
-
When was Shanghai Genomics acquired?
Shanghai Genomics was acquired on 20-Jun-2005.
-
Who acquired Shanghai Genomics?
Shanghai Genomics was acquired by GNI Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »